Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.22.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues $ 4,138 $ 3,868
Cost of revenues 1,943 1,424
Gross profit 2,195 2,444
Research and development expenses 5,877 3,809
Sales and marketing expenses 1,917 1,063
General and administrative expenses 4,125 1,714
Operating loss 9,724 4,142
Financial expenses (income), net 171 (412)
Net loss and comprehensive loss $ 9,895 $ 3,730
Basic and diluted net loss per share (in Dollars per share) $ 0.35 $ 0.22
Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in Shares) 28,548,676 17,128,903